The approval is for the treatment of adult patients with SARS-CoV-2-induced acute respiratory distress syndrome or ARDS who are receiving systemic corticosteroids as part of standard care and ...
Acute respiratory distress syndrome (ARDS) is present in >10% of all people admitted to critical care and is associated with severe morbidity and mortality. Despite more than half a century since its ...
About Veru Inc. Veru is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of cardiometabolic diseases, oncology, and ARDS. The Company’s drug ...
Wable said the relatives of the patient informed the hospital authorities he did not have any other illness like cough or loose motion in the 10 to 12 days before he was admitted for GBS treatment. He ...
A young wife and mom, married with two delightful children, became seriously ill. She was admitted to a local hospital, but her infection worsened to the acute respiratory distress syndrome (ARDS) ...
other treatments with varying levels of intensity ... IC also showed a higher probability of positive absolute risk differences (ARDs) in abstinence at 3 months vs. QL and QL+ with 99% and 98% ...
InflaRx (NASDAQ:IFRX) has received EU regulatory approval for its treatment Gohibic for the treatment of COVID-19 patients experiencing acute respiratory distress. The European Commission granted ...
Ben Condon, who was two months old, died at Bristol Children’s Hospital in April 2015 after developing a respiratory illness.
A Co Down man cheered on by Carl Frampton as he ran almost 60 miles as part of a Prostate Cancer UK fundraising campaign has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback